Guillem Masferrer

deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics. We are based in Barcelona, Spain.

At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal, and accessible mental health support by combining evidence, cutting-edge tech, and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. Designed to help your employees find the right mental healthcare at the right time, Koa Health’s comprehensive care model, Koa Care 360 offers employees simple navigation and personalized, evidence-based care built with the world’s leading clinician-academics. Koa Health provides an integrated approach to care that delivers mental health for everyone, whether they prefer digital-first care or would benefit from clinical services delivered by a human. Available to more than 3 million users worldwide, Koa Health addresses the full continuum of mental health needs – from prevention to treatment. Backed by leading investors such as Morningside, Ancora Finance Group, Wellington Partners Life Sciences, and MTIP, Koa Health leverages deep clinical expertise, research, and technology to deliver effective and accessible care that adapts to users’ unique circumstances, leading to lasting behavior change and positive health outcomes across the full continuum of mental health. Want to learn more about life at Koa Health? Visit our website at koahealth.com Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com

High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology

Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.

Sidekick Health is a digital therapeutics company that helps people prevent and manage chronic diseases. Our approach combines behavioral economics, gamification, and artificial intelligence for an engaging experience that removes barriers to health behavior change and expands the possibilities of well-being. Together with our pharmaceutical and insurance partners, we design personalized lifestyle change programs that improve health outcomes and treatment adherence, create connections between patients and clinicians, and deliver data insights into some of the world's most pressing health challenges.

MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare

Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.

SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.

We build the most effective holistic companion for every individual with digestive issues that guides through everyone's healthcare journey. We take digestive health beyond the pill, bringing together behavioral, microbial and nutritional data.

"Amelia Virtual Care - formerly known as Psious - is an easy-to-use, fast and affordable virtual reality tool for mental health professionals. Founded in 2014, based in Mountain View, CA and Barcelona, ​​Amelia supports psychologists and mental health professionals around the world who perform mental health assessments and interventions. It provides professionals with tools that can help them individualize and simplify processes for each and every individual.

Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges.

Our Mission is to Support Timely, Efficient Patient Care, while Optimizing Laboratory and Hospital Processes & Operations. At STAT-Dx we believe in Fast Syndromic Testing to move innovative diagnostics Closer to Care. Make a difference in healthcare and join us! www.stat-dx.com

AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in the building and management of our companies. Not just investors, we consider ourselves as partners and collaborators to our portfolio companies.

deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics. We are based in Barcelona, Spain.

At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal, and accessible mental health support by combining evidence, cutting-edge tech, and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. Designed to help your employees find the right mental healthcare at the right time, Koa Health’s comprehensive care model, Koa Care 360 offers employees simple navigation and personalized, evidence-based care built with the world’s leading clinician-academics. Koa Health provides an integrated approach to care that delivers mental health for everyone, whether they prefer digital-first care or would benefit from clinical services delivered by a human. Available to more than 3 million users worldwide, Koa Health addresses the full continuum of mental health needs – from prevention to treatment. Backed by leading investors such as Morningside, Ancora Finance Group, Wellington Partners Life Sciences, and MTIP, Koa Health leverages deep clinical expertise, research, and technology to deliver effective and accessible care that adapts to users’ unique circumstances, leading to lasting behavior change and positive health outcomes across the full continuum of mental health. Want to learn more about life at Koa Health? Visit our website at koahealth.com Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com

High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology

Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.